Rare Disease Report
Physicians
Physicians
Patients & Caregivers

Pfizer's Rare Disease Programs

NOVEMBER 09, 2015
Bert Bruce, MBA



 At NORD's Rare Diseases and Orphan Products Breakthrough Summit, we talked with Bert Bruce,  MBA, vice president of Rare Disease Commercial Development at Pfizer, about some of the programs  his company has in development - including drugs to treat patients with Duchenne muscular dystrophy, sickle cell disease, and hemophilia B.

Copyright © RareDR 2013-2017 Rare Disease Communications. All Rights Reserved.